MHC-I-mediated antigen presentation is crucial for CD8+ T-cell cytotoxicity and is one of the key factors in endogenous adaptive immune response development as well as T-cell mediated immunotherapy efficacy in cancer. The gene discussed is CD8A; the disease is cancer.